Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study

Diabetes Research and Clinical Practice

Volumn 74, Issue SUPPL. 2, 2006, Pages

  Hoogma, Roel P L M ^a   Hoekstra, Joost B ^b   Michels, Bob P ^b   Levi, Marcel ^b  

^a GROENE HART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Continuous subcutaneous insulin infusion; Hypoglycaemia; Multiple daily injections; Quality of life; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETIC MICROANGIOPATHY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33845503903     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(06)70019-5     Document Type: Article

References (8)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
2. Nathan D.M., Lachin J., Cleary P., Orchard T., Brillon D.J., Backlund J.Y., et al. Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348 23 (2003) 2294-2303
3. Hart H.E., Bilo H.J., Redekop W.K., Stolk R.P., Assink J.H., and Meyboom-de Jong B. Quality of life of patients with type I diabetes mellitus. Qual Life Res 12 8 (2003) 1089-1097
4. Knight G. Risks with continuous subcutaneous insulin infusion can be serious. BMJ 319 (1999) 104-106
5. Lenhard M.J., and Reeves G.D. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 161 (2001) 2293-2300
6. Pickup J., Mattock M., and Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 324 (2002) 1-6
7. Lalli C., Ciofetta M., Del Sindaco P., Torlone E., Pampanelli S., Compagnucci P., et al. Long-term intensive treatment of Type 1 diabetes with the short-acting insulin analogue lispro in variable combination with NPH insulin at mealtime. Diabetes Care 22 (1999) 468-477
8. Hoogma R.P.L.M., Hammond P.J.P.J., Gomis R., Kerr D., Bruttomesso D., Bouter P., Wiefels K.J., et al. on behalf of the 5-Nations Study Group: Comparison of continuous subcutaneous insulin infusion (CSII) vs. NPH-based multiple daily insulin injections (MDI) in regard to metabolic control and quality of life. Results of the 5-Nations trial. Diabetic Medicine 23 (2006) 141-147